Taguchi K, Motohashi H, Yamamoto M. Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells. 2011;16(2):123–40.

CAS  PubMed  Google Scholar 

Rojo AI, Buttari B, Cadenas S, Carlos AR, Cuadrado A, Falcao AS, et al. Model organisms for investigating the functional involvement of NRF2 in non-communicable diseases. Redox Biol. 2025;79: 103464.

CAS  PubMed  Google Scholar 

Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol. 2007;47:89–116.

CAS  PubMed  Google Scholar 

Hayes JD, Dinkova-Kostova AT. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem Sci. 2014;39(4):199–218.

CAS  PubMed  Google Scholar 

Harvey CJ, Thimmulappa RK, Sethi S, Kong X, Yarmus L, Brown RH, et al. Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model. Sci Transl Med. 2011;3(78):78ra32.

PubMed  PubMed Central  Google Scholar 

Ishii T, Mann GE. Redox status in mammalian cells and stem cells during culture in vitro: critical roles of Nrf2 and cystine transporter activity in the maintenance of redox balance. Redox Biol. 2014;2:786–94.

CAS  PubMed  PubMed Central  Google Scholar 

Saddawi-Konefka R, Seelige R, Gross ET, Levy E, Searles SC, Washington A Jr, et al. Nrf2 induces IL-17D to mediate tumor and virus surveillance. Cell Rep. 2016;16(9):2348–58.

CAS  PubMed  PubMed Central  Google Scholar 

Kobayashi EH, Suzuki T, Funayama R, Nagashima T, Hayashi M, Sekine H, et al. Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. Nat Commun. 2016;7:11624.

CAS  PubMed  PubMed Central  Google Scholar 

Toledano MB, Leonard WJ. Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci USA. 1991;88(10):4328–32.

CAS  PubMed  PubMed Central  Google Scholar 

Morgan MJ, Liu ZG. Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res. 2011;21(1):103–15.

CAS  PubMed  Google Scholar 

Cuadrado A, Martin-Moldes Z, Ye J, Lastres-Becker I. Transcription factors NRF2 and NF-kappaB are coordinated effectors of the Rho family, GTP-binding protein RAC1 during inflammation. J Biol Chem. 2014;289(22):15244–58.

CAS  PubMed  PubMed Central  Google Scholar 

Banning A, Brigelius-Flohe R. NF-kappaB, Nrf2, and HO-1 interplay in redox-regulated VCAM-1 expression. Antioxid Redox Signal. 2005;7(7–8):889–99.

CAS  PubMed  Google Scholar 

Wenzel P, Rossmann H, Muller C, Kossmann S, Oelze M, Schulz A, et al. Heme oxygenase-1 suppresses a pro-inflammatory phenotype in monocytes and determines endothelial function and arterial hypertension in mice and humans. Eur Heart J. 2015;36(48):3437–46.

CAS  PubMed  Google Scholar 

Bourdonnay E, Morzadec C, Fardel O, Vernhet L. Redox-sensitive regulation of gene expression in human primary macrophages exposed to inorganic arsenic. J Cell Biochem. 2009;107(3):537–47.

CAS  PubMed  Google Scholar 

Tong KI, Katoh Y, Kusunoki H, Itoh K, Tanaka T, Yamamoto M. Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model. Mol Cell Biol. 2006;26(8):2887–900.

CAS  PubMed  PubMed Central  Google Scholar 

McMahon M, Thomas N, Itoh K, Yamamoto M, Hayes JD. Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a “tethering” mechanism: a two-site interaction model for the Nrf2-Keap1 complex. J Biol Chem. 2006;281(34):24756–68.

CAS  PubMed  Google Scholar 

Dinkova-Kostova AT, Hakomaki H, Levonen AL. Electrophilic metabolites targeting the KEAP1/NRF2 partnership. Curr Opin Chem Biol. 2024;78: 102425.

CAS  PubMed  Google Scholar 

Sato M, Yaguchi N, Iijima T, Muramatsu A, Baird L, Suzuki T, et al. Sensor systems of KEAP1 uniquely detecting oxidative and electrophilic stresses separately In vivo. Redox Biol. 2024;77: 103355.

CAS  PubMed  PubMed Central  Google Scholar 

Horie Y, Suzuki T, Inoue J, Iso T, Wells G, Moore TW, et al. Molecular basis for the disruption of Keap1-Nrf2 interaction via Hinge & Latch mechanism. Commun Biol. 2021;4(1):576.

CAS  PubMed  PubMed Central  Google Scholar 

Culletta G, Buttari B, Arese M, Brogi S, Almerico AM, Saso L, et al. Natural products as non-covalent and covalent modulators of the KEAP1/NRF2 pathway exerting antioxidant effects. Eur J Med Chem. 2024;270: 116355.

CAS  PubMed  Google Scholar 

Sharma RS, Harrison DJ, Kisielewski D, Cassidy DM, McNeilly AD, Gallagher JR, et al. Experimental nonalcoholic steatohepatitis and liver fibrosis are ameliorated by pharmacologic activation of Nrf2 (NF-E2 p45-Related Factor 2). Cell Mol Gastroenterol Hepatol. 2018;5(3):367–98.

PubMed  Google Scholar 

Cui X, Zong S, Song W, Wang C, Liu Y, Zhang L, et al. Omaveloxolone ameliorates cognitive dysfunction in APP/PS1 mice by stabilizing the STAT3 pathway. Life Sci. 2023;335: 122261.

CAS  PubMed  Google Scholar 

Innamorato NG, Rojo AI, Garcia-Yague AJ, Yamamoto M, de Ceballos ML, Cuadrado A. The transcription factor Nrf2 is a therapeutic target against brain inflammation. J Immunol. 2008;181(1):680–9.

CAS  PubMed  Google Scholar 

Uruno A, Matsumaru D, Ryoke R, Saito R, Kadoguchi S, Saigusa D, et al. Nrf2 suppresses oxidative stress and inflammation in app knock-in Alzheimer’s disease model mice. Mol Cell Biol. 2020;40(6): e00467.

CAS  PubMed  PubMed Central  Google Scholar 

Seedorf K, Weber C, Vinson C, Berger S, Vuillard LM, Kiss A, et al. Selective disruption of NRF2-KEAP1 interaction leads to NASH resolution and reduction of liver fibrosis in mice. JHEP Rep. 2023;5(4): 100651.

PubMed  Google Scholar 

Wang J, Cao Y, Lu Y, Zhu H, Zhang J, Che J, et al. Recent progress and applications of small molecule inhibitors of Keap1-Nrf2 axis for neurodegenerative diseases. Eur J Med Chem. 2024;264: 115998.

CAS  PubMed  Google Scholar 

Crisman E, Duarte P, Dauden E, Cuadrado A, Rodriguez-Franco MI, Lopez MG, et al. KEAP1-NRF2 protein-protein interaction inhibitors: design, pharmacological properties and therapeutic potential. Med Res Rev. 2023;43(1):237–87.

CAS  PubMed  Google Scholar 

Rada P, Rojo AI, Chowdhry S, McMahon M, Hayes JD, Cuadrado A. SCF/beta-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner. Mol Cell Biol. 2011;31(6):1121–33.

CAS  PubMed  PubMed Central  Google Scholar 

Rada P, Rojo AI, Evrard-Todeschi N, Innamorato NG, Cotte A, Jaworski T, et al. Structural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3/beta-TrCP axis. Mol Cell Biol. 2012;32(17):3486–99.

CAS  PubMed  PubMed Central  Google Scholar 

Chowdhry S, Zhang Y, McMahon M, Sutherland C, Cuadrado A, Hayes JD. Nrf2 is controlled by two distinct beta-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. Oncogene. 2013;32(32):3765–81.

CAS  PubMed  Google Scholar 

Bi Y, Cui D, Xiong X, Zhao Y. The characteristics and roles of beta-TrCP1/2 in carcinogenesis. FEBS J. 2021;288(11):3351–74.

CAS  PubMed  Google Scholar 

Fernandez-Gines R, Encinar JA, Hayes JD, Oliva B, Rodriguez-Franco MI, Rojo AI, et al. An inhibitor of interaction between the transcription factor NRF2 and the E3 ubiquitin ligase adapter beta-TrCP delivers anti-inflammatory responses in mouse liver. Redox Biol. 2022;55: 102396.

CAS  PubMed  PubMed Central  Google Scholar 

Fernandez-Gines R, Encinar JA, Escoll M, Carnicero-Senabre D, Jimenez-Villegas J, Garcia-Yague AJ, et al. Specific targeting of the NRF2/beta-TrCP axis promotes beneficial effects in NASH. Redox Biol. 2024;69: 103027.

CAS  PubMed  PubMed Central  Google Scholar 

Rada P, Rojo AI, Offergeld A, Feng GJ, Velasco-Martin JP, Gonzalez-Sancho JM, et al. WNT-3A regulates an Axin1/NRF2 complex that regulates antioxidant metabolism in hepatocytes. Antioxid Redox Signal. 2015;22(7):555–71.

CAS  PubMed  PubMed Central  Google Scholar 

Wang XJ, Hayes JD, Wolf CR. Generation of a stable antioxidant response element-driven reporter gene cell line and its use to show redox-dependent activation of nrf2 by cancer chemotherapeutic agents. Cancer Res. 2006;6